The contact details of the Swissmedic Divisions in the information sheet and the relevant document links have been updated, where necessary. The previous guidelines on reporting clusters of adverse drug reactions have been deleted and replaced by a reference to the relevant sections of the TPA, TPO and the FAQ. Editorial changes have also been made.
The revised information sheet is valid with effect from 1 November 2025.